Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gopalakrishnan Ramakrishnan

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Molecular & Cellular Oncology|June 17, 2016
Characterization of cancer-associated missense mutations in MDM2Krishna M Chauhan, Gopalakrishnan Ramakrishnan, Madhusudhan Kollareddy, et al.
Fundamental & Clinical Pharmacology|March 5, 2010
Hesperidin attenuates mitochondrial dysfunction during benzo(a)pyrene-induced lung carcinogenesis in miceSattu Kamaraj, Pandi Anandakumar, Sundaram Jagan, et al.
Chemico-Biological Interactions|January 24, 2007
Depsipeptide a histone deacetlyase inhibitor down regulates levels of matrix metalloproteinases 2 and 9 mRNA and protein expressions in lung cancer cells (A549)Radhakrishnan Vinodhkumar, Young-Sun Song, Vilwanathan Ravikumar, et al.
Cell Reports|January 11, 2025
Deletion of AMP-activated protein kinase impairs metastasis and is rescued by ROS scavenging or ectopic CD36 expressionGopalakrishnan Ramakrishnan, Alexander R Terry, Veronique Nogueira, et al.
Diabetes & Vascular Disease Research|January 27, 2012
The association between insulin and low-density lipoprotein receptorsGopalakrishnan Ramakrishnan, Albina Arjuman, Shilpa Suneja, et al.
Biological & Pharmaceutical Bulletin|December 7, 2007
The effects of quercetin on antioxidant status and tumor markers in the lung and serum of mice treated with benzo(a)pyreneSattu Kamaraj, Radhakrishnan Vinodhkumar, Pandi Anandakumar, et al.
Oncotarget|February 13, 2016
Mutant p53 protects ETS2 from non-canonical COP1/DET1 dependent degradationZunamys I Carrero, Madhusudhan Kollareddy, Krishna M Chauhan, et al.
Biochimica Et Biophysica Acta|May 31, 2011
Bimodal regulation of FoxO3 by AKT and 14-3-3Melissa Dobson, Gopalakrishnan Ramakrishnan, Stephanie Ma, et al.
Molecular and Cellular Biochemistry|April 1, 2008
Silymarin downregulates COX-2 expression and attenuates hyperlipidemia during NDEA-induced rat hepatocellular carcinomaGopalakrishnan Ramakrishnan, Carmen Martha Elinos-Báez, Sundaram Jagan, et al.
The Journal of Biological Chemistry|January 22, 2014
Sirt2 deacetylase is a novel AKT binding partner critical for AKT activation by insulinGopalakrishnan Ramakrishnan, Gantulga Davaakhuu, Ludmila Kaplun, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Molecular & Cellular Oncology|June 17, 2016
Characterization of cancer-associated missense mutations in MDM2Krishna M Chauhan, Gopalakrishnan Ramakrishnan, Madhusudhan Kollareddy, et al.
Fundamental & Clinical Pharmacology|March 5, 2010
Hesperidin attenuates mitochondrial dysfunction during benzo(a)pyrene-induced lung carcinogenesis in miceSattu Kamaraj, Pandi Anandakumar, Sundaram Jagan, et al.
Chemico-Biological Interactions|January 24, 2007
Depsipeptide a histone deacetlyase inhibitor down regulates levels of matrix metalloproteinases 2 and 9 mRNA and protein expressions in lung cancer cells (A549)Radhakrishnan Vinodhkumar, Young-Sun Song, Vilwanathan Ravikumar, et al.
Cell Reports|January 11, 2025
Deletion of AMP-activated protein kinase impairs metastasis and is rescued by ROS scavenging or ectopic CD36 expressionGopalakrishnan Ramakrishnan, Alexander R Terry, Veronique Nogueira, et al.
Diabetes & Vascular Disease Research|January 27, 2012
The association between insulin and low-density lipoprotein receptorsGopalakrishnan Ramakrishnan, Albina Arjuman, Shilpa Suneja, et al.
Biological & Pharmaceutical Bulletin|December 7, 2007
The effects of quercetin on antioxidant status and tumor markers in the lung and serum of mice treated with benzo(a)pyreneSattu Kamaraj, Radhakrishnan Vinodhkumar, Pandi Anandakumar, et al.
Oncotarget|February 13, 2016
Mutant p53 protects ETS2 from non-canonical COP1/DET1 dependent degradationZunamys I Carrero, Madhusudhan Kollareddy, Krishna M Chauhan, et al.
Biochimica Et Biophysica Acta|May 31, 2011
Bimodal regulation of FoxO3 by AKT and 14-3-3Melissa Dobson, Gopalakrishnan Ramakrishnan, Stephanie Ma, et al.
Molecular and Cellular Biochemistry|April 1, 2008
Silymarin downregulates COX-2 expression and attenuates hyperlipidemia during NDEA-induced rat hepatocellular carcinomaGopalakrishnan Ramakrishnan, Carmen Martha Elinos-Báez, Sundaram Jagan, et al.
The Journal of Biological Chemistry|January 22, 2014
Sirt2 deacetylase is a novel AKT binding partner critical for AKT activation by insulinGopalakrishnan Ramakrishnan, Gantulga Davaakhuu, Ludmila Kaplun, et al.
Pageof 3